|
1.
|
Thorgeirsson SS and Grisham JW: Molecular
pathogenesis of human hepatocellular carcinoma. Nat Genet.
31:339–346. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
3.
|
Bruix J, Boix L, Sala M and Llovet JM:
Focus on hepatocellular carcinoma. Cancer Cell. 5:215–219. 2004.
View Article : Google Scholar
|
|
4.
|
Iizuka N, Oka M, Yamada-Okabe H, Nishida
M, Maeda Y, Mori N, Takao T, Tamesa T, Tangoku A, Tabuchi H, Hamada
K, Nakayama H, Ishitsuka H, Miyamoto T, Hirabayashi A, Uchimura S
and Hamamoto Y: Oligonucleotide microarray for prediction of early
intrahepatic recurrence of hepatocellular carcinoma after curative
resection. Lancet. 361:923–929. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Takata M, Yamanaka N, Tanaka T, Yamanaka
J, Maeda S, Okamoto E, Yasojima H, Uematsu K, Watanabe H and
Uragari Y: What patients can survive disease free after complete
resection for hepatocellular carcinoma? A multivariate analysis.
Jpn J Clin Oncol. 30:75–81. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Yang XR, Xu Y, Yu B, Zhou J, Li JC, Qiu
SJ, Shi YH, Wang XY, Dai Z, Shi GM, Wu B, Wu LM, Yang GH, Zhang BH,
Qin WX and Fan J: CD24 is a novel predictor for poor prognosis of
hepatocellular carcinoma after surgery. Clin Cancer Res.
15:5518–5527. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Tsutsui M, Iizuka N, Moribe T, Miura T,
Kimura N, Tamatsukuri S, Ishitsuka H, Fujita Y, Hamamoto Y,
Tsunedomi R, Iida M, Tokuhisa Y, Sakamoto K, Tamesa T, Sakaida I
and Oka M: Methylated cyclin D2 gene circulating in the blood as a
prognosis predictor of hepatocellular carcinoma. Clin Chim Acta.
411:516–520. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Villanueva A, Hoshida Y, Toffanin S,
Lachenmayer A, Alsinet C, Savic R, Cornella H and Llovet JM: New
strategies in hepato-cellular carcinoma: genomic prognostic
markers. Clin Cancer Res. 16:4688–4694. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Villanueva A, Hoshida Y, Battiston C,
Tovar V, Sia D, Alsinet C, Cornella H, Liberzon A, Kobayashi M,
Kumada H, Thung SN, Bruix J, Newell P, April C, Fan JB, Roayaie S,
Mazzaferro V, Schwartz ME and Llovet JM: Combining clinical,
pathology and gene expression data to predict recurrence of
hepatocellular carcinoma. Gastroenterology. 140:1501–1512. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Hagiwara S, Kudo M, Chung H, Ueshima K,
Inoue T, Haji S, Watanabe T, Park AM, Munakata H and Sakurai T:
Activation of c-Jun N-terminal kinase in non-cancerous liver tissue
predicts a high risk of recurrence after hepatic resection for
hepatocellular carcinoma. Hepatol Res. 42:394–400. 2012. View Article : Google Scholar
|
|
11.
|
Augello C, Vaira V, Caruso L, Destro A,
Maggioni M, Park YN, Montorsi M, Santambrogio R, Roncalli M and
Bosari S: MicroRNA profiling of hepatocarcinogenesis identifies
C19MC cluster as a novel prognostic biomarker in hepatocellular
carcinoma. Liver Int. 32:772–782. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Tsunedomi R, Iizuka N, Yamada-Okabe H,
Tamesa T, Okada T, Sakamoto K, Takashima M, Hamaguchi T, Miyamoto
T, Uchimura S, Hamamoto Y, Yamada M and Oka M: Identification of
ID2 associated with invasion of hepatitis C virus-related
hepatocellular carcinoma by gene expression profile. Int J Oncol.
29:1445–1451. 2006.PubMed/NCBI
|
|
13.
|
Tsunedomi R, Iizuka N, Tamesa T, Sakamoto
K, Hamaguchi T, Somura H, Yamada M and Oka M: Decreased ID2
promotes metastatic potentials of hepatocellular carcinoma by
altering secretion of vascular endothelial growth factor. Clin
Cancer Res. 14:1025–1031. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Vauthey JN, Lauwers GY, Esnaola NF, Do KA,
Belghiti J, Mirza N, Curley SA, Ellis LM, Regimbeau JM, Rashid A,
Cleary KR and Nagorney DM: Simplified staging for hepatocellular
carcinoma. J Clin Oncol. 20:1527–1536. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Bonnet D and Dick JE: Human acute leukemia
is organized as a hierarchy that originates from a primitive
hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Prince ME, Sivanandan R, Kaczorowski A,
Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF and Ailles
LE: Identification of a subpopulation of cells with cancer stem
cell properties in head and neck squamous cell carcinoma. Proc Natl
Acad Sci USA. 104:973–978. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
O’Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110.
2007.PubMed/NCBI
|
|
22.
|
Chiba T, Kita K, Zheng YW, Yokosuka O,
Saisho H, Iwama A, Nakauchi H and Taniguchi H: Side population
purified from hepatocellular carcinoma cells harbors cancer stem
cell-like properties. Hepatology. 44:240–251. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Zhou S, Schuetz JD, Bunting KD, Colapietro
AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M,
Nakauchi H and Sorrentino BP: The ABC transporter Bcrp1/ABCG2 is
expressed in a wide variety of stem cells and is a molecular
determinant of the side-population phenotype. Nat Med. 7:1028–1034.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Zhou S, Morris JJ, Barnes Y, Lan L,
Schuetz JD and Sorrentino BP: Bcrp1 gene expression is required for
normal numbers of side population stem cells in mice and confers
relative protection to mitoxantrone in hematopoietic cells in vivo.
Proc Natl Acad Sci USA. 99:12339–12344. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Hirschmann-Jax C, Foster AE, Wulf GG,
Nuchtern JG, Jax TW, Gobel U, Goodell MA and Brenner MK: A distinct
‘side population’ of cells with high drug efflux capacity in human
tumor cells. Proc Natl Acad Sci USA. 101:14228–14233. 2004.
|
|
26.
|
Mitsuhashi N, Miki T, Senbongi H, Yokoi N,
Yano H, Miyazaki M, Nakajima N, Iwanaga T, Yokoyama Y, Shibata T
and Seino S: MTABC3, a novel mitochondrial ATP-binding cassette
protein involved in iron homeostasis. J Biol Chem. 275:17536–17540.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Krishnamurthy PC, Du G, Fukuda Y, Sun D,
Sampath J, Mercer KE, Wang J, Sosa-Pineda B, Murti KG and Schuetz
JD: Identification of a mammalian mitochondrial porphyrin
transporter. Nature. 443:586–589. 2006.PubMed/NCBI
|
|
28.
|
Szakács G, Annereau JP, Lababidi S,
Shankavaram U, Arciello A, Bussey KJ, Reinhold W, Guo Y, Kruh GD,
Reimers M, Weinstein JN and Gottesman MM: Predicting drug
sensitivity and resistance: profiling ABC transporter genes in
cancer cells. Cancer Cell. 6:129–137. 2004.PubMed/NCBI
|
|
29.
|
Yasui K, Mihara S, Zhao C, Okamoto H,
Saito-Ohara F, Tomida A, Funato T, Yokomizo A, Naito S, Imoto I,
Tsuruo T and Inazawa J: Alteration in copy numbers of genes as a
mecha nism for acquired drug resistance. Cancer Res. 64:1403–1410.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Park S, Shimizu C, Shimoyama T, Takeda M,
ando M, Kohno T, Katsumata N, Kang YK, Nishio K and Fujiwara Y:
Gene expression profiling of ATP-binding cassette (ABC)
transporters as a predictor of the pathologic response to
neoadjuvant chemo-therapy in breast cancer patients. Breast Cancer
Res Treat. 99:9–17. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Paterson JK, Shukla S, Black CM, Tachiwada
T, Garfield S, Wincovitch S, Ernst DN, Agadir A, Li X, Ambudkar SV,
Szakacs G, Akiyama S and Gottesman MM: Human ABCB6 localizes to
both the outer mitochondrial membrane and the plasma membrane.
Biochemistry. 46:9443–9452. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Kelter G, Steinbach D, Konkimalla VB,
Tahara T, Taketani S, Fiebig HH and Efferth T: Role of transferrin
receptor and the ABC transporters ABCB6 and ABCB7 for resistance
and differentiation of tumor cells towards artesunate. PLoS One.
2:e7982007. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Ulrich DL, Lynch J, Wang Y, Fukuda Y,
Nachagari D, Du G, Sun D, Fan Y, Tsurkan L, Potter PM, Rehg JE and
Schuetz JD: ATP-dependent mitochondrial porphyrin importer ABCB6
protects against phenylhydrazine toxicity. J Biol Chem.
287:12679–12690. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Esteller M, Corn PG, Baylin SB and Herman
JG: A gene hyper-methylation profile of human cancer. Cancer Res.
61:3225–3229. 2001.PubMed/NCBI
|
|
35.
|
Jones PA and Baylin SB: The fundamental
role of epigenetic events in cancer. Nat Rev Genet. 3:415–428.
2002.PubMed/NCBI
|
|
36.
|
Herman JG and Baylin SB: Gene silencing in
cancer in association with promoter hypermethylation. N Engl J Med.
349:2042–2054. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Tsunedomi R, Ogawa Y, Iizuka N, Sakamoto
K, Tamesa T, Moribe T and Oka M: The assessment of methylated BASP1
and SRD5A2 levels in the detection of early hepatocellular
carcinoma. Int J Oncol. 36:205–212. 2010.PubMed/NCBI
|
|
38.
|
Eads CA, Danenberg KD, Kawakami K, Saltz
LB, Blake C, Shibata D, Danenberg PV and Laird PW: MethyLight: a
high-throughput assay to measure DNA methylation. Nucleic Acids
Res. 28:E322000. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Iizuka N, Oka M, Yamada-Okabe H, Mori N,
Tamesa T, Okada T, Takemoto N, Tangoku A, Hamada K, Nakayama H,
Miyamoto T, Uchimura S and Hamamoto Y: Comparison of gene
expression profiles between hepatitis B virus- and hepatitis C
virus-infected hepatocellular carcinoma by oligonucleotide
microarray data on the basis of a supervised learning method.
Cancer Res. 62:3939–3944. 2002.
|
|
40.
|
Iizuka N, Oka M, Yamada-Okabe H, Mori N,
Tamesa T, Okada T, Takemoto N, Sakamoto K, Hamada K, Ishitsuka H,
Miyamoto T, Uchimura S and Hamamoto Y: Self-organizing-map-based
molecular signature representing the development of hepato cellular
carcinoma. FEBS Lett. 579:1089–1100. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Polireddy K, Chavan H, Abdulkarim BA and
Krishnamurthy P: Functional significance of the ATP-binding
cassette transporter B6 in hepatocellular carcinoma. Mol Oncol.
5:410–425. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Borel F, Han R, Visser A, Petry H, van
Deventer SJ, Jansen PL and Konstantinova P: Adenosine
triphosphate-binding cassette transporter genes up-regulation in
untreated hepatocellular carcinoma is mediated by cellular
microRNAs. Hepatology. 55:821–832. 2012. View Article : Google Scholar
|
|
43.
|
Yamashita T, Ji J, Budhu A, Forgues M,
Yang W, Wang HY, Jia H, Ye Q, Qin LX, Wauthier E, Reid LM, Minato
H, Honda M, Kaneko S, Tang ZY and Wang XW: EpCAM-positive
hepato-cellular carcinoma cells are tumor-initiating cells with
stem/progenitor cell features. Gastroenterology. 136:1012–1024.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Chen X, Lingala S, Khoobyari S, Nolta J,
Zern MA and Wu J: Epithelial mesenchymal transition and hedgehog
signaling activation are associated with chemoresistance and
invasion of hepatoma subpopulations. J Hepatol. 55:838–845. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Kalinowski DS and Richardson DR: The
evolution of iron chelators for the treatment of iron overload
disease and cancer. Pharmacol Rev. 57:547–583. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Miller LD, Coffman LG, Chou JW, Black MA,
Bergh J, D’Agostino R Jr, Torti SV and Torti FM: An iron regulatory
gene signature predicts outcome in breast cancer. Cancer Res.
71:6728–6737. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Yu Y, Kovacevic Z and Richardson DR:
Tuning cell cycle regulation with an iron key. Cell Cycle.
6:1982–1994. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48.
|
Yamasaki T, Terai S and Sakaida I:
Deferoxamine for advanced hepatocellular carcinoma. N Engl J Med.
365:576–578. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49.
|
Esteller M: Epigenetics in cancer. N Engl
J Med. 358:1148–1159. 2008. View Article : Google Scholar
|
|
50.
|
Miao F, Wu X, Zhang L, Yuan YC, Riggs AD
and Natarajan R: Genome-wide analysis of histone lysine methylation
variations caused by diabetic conditions in human monocytes. J Biol
Chem. 282:13854–13863. 2007. View Article : Google Scholar : PubMed/NCBI
|
